CKD-314 (Nafabelltan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CKD-314 (Nafabelltan), covering 2021-02-02 to 2021-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia [Phase 2]